Rapport Therapeutics, Inc. RAPP Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s short-term investments?
- Rapport Therapeutics, Inc. (RAPP) reported short-term investments of $398.73M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s short-term investments changed year-over-year?
- Rapport Therapeutics, Inc.'s short-term investments increased by 75.1% year-over-year, from $227.78M to $398.73M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s short-term investments has grown at a 138.0% compound annual growth rate (CAGR), from $77.31M to $437.89M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.